Evidence map›Paper›PMID 32581221›Full record

ArticleScientific reports2020

Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies.

R Da-Ano, I Masson, F Lucia, M Doré, P Robin, J Alfieri, C Rousseau, A Mervoyer, C Reinhold, J Castelli and 6 more

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05151718 (Ependymomics), which is not on this map. Cited by 121 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05151718 recruitingnot on this mapstarted 2021, after this paper: background citation

Ependymomics: Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

TypeobservationalSponsorInstitut Claudius RegaudRan2021 to 2026Enrolled370ConditionsEpendymoma of Brain, Pediatric Solid Tumor
3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

R Da-AnoINSERM, UMR 1101, LaTIM, University of Brest, Brest, France. ronrickarnaiz@gmail.com.
I MassonINSERM, UMR 1101, LaTIM, University of Brest, Brest, France.
F LuciaINSERM, UMR 1101, LaTIM, University of Brest, Brest, France.
M DoréDepartment of Radiation Oncology, Institut de cancérologie de l'Ouest René-Gauducheau, Saint-Herblain, France.
P RobinDepartment of Nuclear Medicine, University of Brest, Brest, France.
J AlfieriDepartment of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada.
C RousseauDepartment of Nuclear Medicine, Institut de cancerologie de l'Ouest René-Gauducheau, Saint-Herblain, France.
A MervoyerDepartment of Radiation Oncology, Institut de cancérologie de l'Ouest René-Gauducheau, Saint-Herblain, France.
C ReinholdDepartment of Radiology, McGill University Health Centre, Montreal, Canada.
J CastelliRadiotherapy Department Cancer, Institute Eugene Marquis, Rennes, France.
R De CrevoisierRadiotherapy Department Cancer, Institute Eugene Marquis, Rennes, France.
J F RameéDepartment of Medical Oncology, Centre Hospitalier de Vendee, La Roche sur Yon, France.
O PradierINSERM, UMR 1101, LaTIM, University of Brest, Brest, France.
U SchickINSERM, UMR 1101, LaTIM, University of Brest, Brest, France.
D Visvikis *INSERM, UMR 1101, LaTIM, University of Brest, Brest, France.
M Hatt *INSERM, UMR 1101, LaTIM, University of Brest, Brest, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multicenter studies are needed to demonstrate the clinical potential value of radiomics as a prognostic tool. However, variability in scanner models, acquisition protocols and reconstruction settings are unavoidable and radiomic features are notoriously sensitive to these factors, which hinders pooling them in a statistical analysis. A statistical harmonization method called ComBat was developed to deal with the "batch effect" in gene expression microarray data and was used in radiomics studies to deal with the "center-effect". Our goal was to evaluate modifications in ComBat allowing for more flexibility in choosing a reference and improving robustness of the estimation. Two modified ComBat versions were evaluated: M-ComBat allows to transform all features distributions to a chosen reference, instead of the overall mean, providing more flexibility. B-ComBat adds bootstrap and Monte Carlo for improved robustness in the estimation. BM-ComBat combines both modifications. The four versions were compared regarding their ability to harmonize features in a multicenter context in two different clinical datasets. The first contains 119 locally advanced cervical cancer patients from 3 centers, with magnetic resonance imaging and positron emission tomography imaging. In that case ComBat was applied with 3 labels corresponding to each center. The second one contains 98 locally advanced laryngeal cancer patients from 5 centers with contrast-enhanced computed tomography. In that specific case, because imaging settings were highly heterogeneous even within each of the five centers, unsupervised clustering was used to determine two labels for applying ComBat. The impact of each harmonization was evaluated through three different machine learning pipelines for the modelling step in predicting the clinical outcomes, across two performance metrics (balanced accuracy and Matthews correlation coefficient). Before harmonization, almost all radiomic features had significantly different distributions between labels. These differences were successfully removed with all ComBat versions. The predictive ability of the radiomic models was always improved with harmonization and the improved ComBat provided the best results. This was observed consistently in both datasets, through all machine learning pipelines and performance metrics. The proposed modifications allow for more flexibility and robustness in the estimation. They also slightly but consistently improve the predictive power of resulting radiomic models.

Indexed as

FemaleHumansLaryngeal NeoplasmsMachine LearningMagnetic Resonance ImagingMulticenter Studies as TopicPositron-Emission TomographyPrognosisRadiographic Image Interpretation, Computer-AssistedUterine Cervical Neoplasms

Identifiers

PMID32581221
PMCPMC7314795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.